Lantern Pharma Inc. (LTRN) ownership: Top institutional holder: BIOS Capital Management, LP ($1.18M). Insider activity: Net Seller (0 buys, 4 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BIOS Capital Management, LP | 864435.00 | $1.18M | 2026-03-31 |
| VANGUARD GROUP INC | 384041.00 | $1.16M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 332079.00 | $454948.00 | 2026-03-31 |
| CM Management, LLC | 250000.00 | $342500.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 116000.00 | $158920.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 111646.00 | $152984.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 32895.00 | $99672.00 | 2025-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28820.00 | $87325.00 | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-12 | |
| Sell | null | 2026-05-12 | |
| Sell | null | 2026-05-12 | |
| Sell | null | 2026-05-12 |
Back to LTRN overview · LTRN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.